9.88
price down icon8.94%   -0.97
after-market アフターアワーズ: 10.15 0.27 +2.73%
loading
前日終値:
$10.85
開ける:
$10.75
24時間の取引高:
2.22M
Relative Volume:
0.93
時価総額:
$1.21B
収益:
$631.73M
当期純損益:
$-239.78M
株価収益率:
-4.8911
EPS:
-2.02
ネットキャッシュフロー:
$-33.45M
1週間 パフォーマンス:
-13.86%
1か月 パフォーマンス:
-17.25%
6か月 パフォーマンス:
-55.83%
1年 パフォーマンス:
-74.35%
1日の値動き範囲:
Value
$9.86
$10.84
1週間の範囲:
Value
$9.86
$11.79
52週間の値動き範囲:
Value
$9.77
$39.30

10 X Genomics Inc Stock (TXG) Company Profile

Name
名前
10 X Genomics Inc
Name
セクター
Healthcare (1169)
Name
電話
(925) 401-7300
Name
住所
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Name
職員
1,306
Name
Twitter
@10xgenomics
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
TXG's Discussions on Twitter

TXG を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Health Information Services icon
TXG
10 X Genomics Inc
9.88 1.21B 631.73M -239.78M -33.45M -2.02
Health Information Services icon
VEEV
Veeva Systems Inc
227.80 36.98B 2.75B 714.14M 1.09B 4.33
Health Information Services icon
SOLV
Solventum Corp
72.30 12.51B 8.26B 66.00M 1.17B 0.3682
Health Information Services icon
DOCS
Doximity Inc
60.80 11.41B 516.85M 174.11M 217.38M 0.87
Health Information Services icon
HQY
Healthequity Inc
93.97 8.14B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
TEM
Tempus Ai Inc
42.16 7.26B 640.44M -743.28M -206.93M -11.29

10 X Genomics Inc Stock (TXG) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-02-13 ダウングレード Leerink Partners Outperform → Market Perform
2024-09-03 開始されました Leerink Partners Outperform
2024-07-22 アップグレード Jefferies Hold → Buy
2024-07-18 ダウングレード JP Morgan Overweight → Neutral
2024-07-10 ダウングレード Deutsche Bank Buy → Hold
2024-06-27 ダウングレード Wolfe Research Outperform → Peer Perform
2024-06-25 ダウングレード Guggenheim Buy → Neutral
2024-06-03 再開されました Jefferies Hold
2024-05-01 ダウングレード TD Cowen Buy → Hold
2023-12-14 開始されました Guggenheim Buy
2023-12-13 開始されました Wolfe Research Outperform
2023-12-12 アップグレード BofA Securities Underperform → Neutral
2023-07-05 再開されました JP Morgan Overweight
2023-05-10 開始されました Barclays Overweight
2023-03-31 開始されました Stephens Overweight
2023-02-02 開始されました UBS Neutral
2022-12-14 開始されました Deutsche Bank Buy
2022-08-18 ダウングレード Goldman Neutral → Sell
2022-07-25 開始されました Canaccord Genuity Buy
2022-07-15 ダウングレード BofA Securities Neutral → Underperform
2022-07-15 ダウングレード William Blair Outperform → Mkt Perform
2021-10-15 再開されました Cowen Outperform
2021-09-14 ダウングレード BofA Securities Buy → Neutral
2021-03-15 開始されました William Blair Outperform
2020-12-02 開始されました Goldman Neutral
2020-09-09 開始されました Morgan Stanley Overweight
2020-07-10 開始されました Stifel Buy
2020-03-05 開始されました Guggenheim Buy
2020-01-07 開始されました Citigroup Buy
2019-10-07 開始されました BofA/Merrill Buy
2019-10-07 開始されました Cowen Outperform
2019-10-07 開始されました JP Morgan Overweight
2019-09-24 開始されました Evercore ISI Outperform
すべてを表示

10 X Genomics Inc (TXG) 最新ニュース

pulisher
Mar 11, 2025

Long Read Sequencing Market Top Companies Study10X Genomics, - openPR

Mar 11, 2025
pulisher
Mar 10, 2025

Bruker motion backfires in US patent dispute with 10x Genomics, Harvard - MLex

Mar 10, 2025
pulisher
Mar 09, 2025

10x Genomics IncOrdinary SharesClass A to Host Earnings Call - ACCESS Newswire

Mar 09, 2025
pulisher
Mar 08, 2025

10x Genomics’ (TXG) Sell (E+) Rating Reiterated at Weiss Ratings - Defense World

Mar 08, 2025
pulisher
Mar 06, 2025

Citigroup Issues Pessimistic Forecast for 10x Genomics (NASDAQ:TXG) Stock Price - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

10x Genomics gets injunction against Parse Biosciences' ATAC Products - MSN

Mar 05, 2025
pulisher
Mar 05, 2025

10x Genomics Dodges Appeal In DNA Analysis Patent Clash - Law 360 UK

Mar 05, 2025
pulisher
Mar 05, 2025

10x genomics CEO Serge Saxonov sells $84,393 in stock By Investing.com - Investing.com Australia

Mar 05, 2025
pulisher
Mar 05, 2025

Rhumbline Advisers Sells 1,641 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

10x genomics CEO Serge Saxonov sells $84,393 in stock - Investing.com

Mar 04, 2025
pulisher
Mar 04, 2025

Sanctuary Advisors LLC Purchases 6,474 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Short Interest in 10x Genomics, Inc. (NASDAQ:TXG) Expands By 34.4% - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

10x Genomics Secures Injunction Against Parse Biosciences' Plann - GuruFocus.com

Mar 03, 2025
pulisher
Mar 03, 2025

10x Genomics Secures Injunction Against Parse Biosciences’ Planned ATAC Products - The Malaysian Reserve

Mar 03, 2025
pulisher
Mar 03, 2025

10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

10x Genomics secures injunction against Parse Biosciences - Investing.com

Mar 03, 2025
pulisher
Mar 03, 2025

10x Genomics gets injunction against Parse Biosciences' ATAC Products (TXG:NASDAQ) - Seeking Alpha

Mar 03, 2025
pulisher
Mar 03, 2025

10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products – Company Announcement - Financial Times

Mar 03, 2025
pulisher
Mar 03, 2025

Patent Victory: How 10x Genomics Just Eliminated a Key Competitor in Genomic Analysis - StockTitan

Mar 03, 2025
pulisher
Mar 02, 2025

10 Promising Biotech Stocks to Invest in (March 2025) - Securities.io

Mar 02, 2025
pulisher
Mar 01, 2025

ARK Investment Management LLC Purchases 1,193,712 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Mar 01, 2025
pulisher
Mar 01, 2025

SVB Wealth LLC Acquires Shares of 522,609 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Mar 01, 2025
pulisher
Feb 28, 2025

Ieq Capital LLC Purchases 50,722 Shares of 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Feb 28, 2025
pulisher
Feb 28, 2025

ING Groep NV Acquires New Shares in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

10x Genomics, Inc. (NASDAQ:TXG) CEO Sells $56,368.44 in Stock - MarketBeat

Feb 27, 2025
pulisher
Feb 27, 2025

Director of 10x Genomics Picks Up 184% More Stock - Simply Wall St

Feb 27, 2025
pulisher
Feb 27, 2025

Oxford Nanopore Expands Compatibility With 10x Genomics To Unlock Deeper Insights in Single-Cell Transcriptomics - Technology Networks

Feb 27, 2025
pulisher
Feb 27, 2025

10x genomics’ president sells $50,602 in stock - Investing.com India

Feb 27, 2025
pulisher
Feb 26, 2025

Insider Buying: 10x Genomics, Inc. (NASDAQ:TXG) Director Buys 40,000 Shares of Stock - MarketBeat

Feb 26, 2025
pulisher
Feb 26, 2025

10x genomics CEO Serge Saxonov sells $56,346 in stock - Investing.com India

Feb 26, 2025
pulisher
Feb 26, 2025

10x genomics CEO Serge Saxonov sells $56,346 in stock By Investing.com - Investing.com South Africa

Feb 26, 2025
pulisher
Feb 26, 2025

10x genomics' president sells $50,602 in stock - Investing.com

Feb 26, 2025
pulisher
Feb 25, 2025

10x genomics director Alan Mateo acquires $445,572 in stock - Investing.com

Feb 25, 2025
pulisher
Feb 25, 2025

10x Genomics Director Mateo Alan Acquires 40,000 Shares - TradingView

Feb 25, 2025
pulisher
Feb 24, 2025

Alberta Investment Management Corp Takes $3.21 Million Position in 10x Genomics, Inc. (NASDAQ:TXG) - MarketBeat

Feb 24, 2025
pulisher
Feb 23, 2025

10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, - GuruFocus.com

Feb 23, 2025
pulisher
Feb 23, 2025

10x Genomics Unveils Innovation Roadmap at AGBT General Meeting, Advancing Leadership in Large-Scale Single Cell and Spatial Analysis - Nasdaq

Feb 23, 2025
pulisher
Feb 23, 2025

Can 10x Genomics' New 8-Million Cell Platform Transform Genomic Research? - StockTitan

Feb 23, 2025
pulisher
Feb 22, 2025

Harvard, 10x Genomics Settle Patent Dispute With Vizgen - Harvard Crimson

Feb 22, 2025
pulisher
Feb 21, 2025

10x Genomics, Inc. (NASDAQ:TXG) Stock's 28% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St

Feb 21, 2025
pulisher
Feb 20, 2025

Weiss Ratings Reiterates Sell (E+) Rating for 10x Genomics (NASDAQ:TXG) - Defense World

Feb 20, 2025
pulisher
Feb 19, 2025

10x Genomics to Participate in the 45th Annual TD Cowen Health Care Conference - The Eastern Progress Online

Feb 19, 2025
pulisher
Feb 19, 2025

10x Genomics, Inc. (NASDAQ:TXG) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

Q1 EPS Estimates for 10x Genomics Lowered by Leerink Partnrs - MarketBeat

Feb 19, 2025
pulisher
Feb 18, 2025

10x Genomics (NASDAQ:TXG) Lowered to "Hold" Rating by Leerink Partnrs - MarketBeat

Feb 18, 2025
pulisher
Feb 17, 2025

10x Genomics (NASDAQ:TXG) Stock Price Up 8.3%Here's What Happened - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

Citigroup Has Lowered Expectations for 10x Genomics (NASDAQ:TXG) Stock Price - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

10x Genomics (NASDAQ:TXG) Price Target Cut to $12.00 by Analysts at JPMorgan Chase & Co. - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

10x Genomics' SWOT analysis: genomics firm faces NIH funding headwinds - Investing.com

Feb 17, 2025
pulisher
Feb 17, 2025

10x Genomics (NASDAQ:TXG) Shares Gap Down on Disappointing Earnings - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

Canaccord Genuity Group Lowers 10x Genomics (NASDAQ:TXG) Price Target to $18.00 - MarketBeat

Feb 17, 2025

10 X Genomics Inc (TXG) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$10.43
price down icon 5.27%
$4.47
price down icon 4.08%
$23.38
price down icon 2.66%
$16.96
price down icon 4.50%
health_information_services WAY
$35.27
price down icon 4.37%
health_information_services TEM
$42.16
price down icon 7.33%
大文字化:     |  ボリューム (24 時間):